Related Experiment Videos

Glycemic crises in patients with hematologic malignancies

B T Daniel1

  • 1Division of Nursing, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

Insights

Patients with blood cancers like leukemia may develop diabetes mellitus. Stress from cancer treatment can lead to life-threatening diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHNS), requiring careful medical management.

Area of Science:

  • Internal Medicine
  • Endocrinology
  • Oncology

Background:

  • Hematologic malignancies (leukemia, lymphoma, myeloma) frequently coexist with other medical conditions, including diabetes mellitus.
  • The physiological and psychological stress associated with cancer diagnosis and treatment can precipitate severe diabetic complications.

Purpose of the Study:

  • To highlight the risk of diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHNS) in patients with hematologic malignancies.
  • To emphasize the importance of heightened awareness among healthcare teams regarding these complex diabetic emergencies.

Main Methods:

  • This is a review and synthesis of existing knowledge regarding the intersection of hematologic malignancies and diabetes mellitus complications.
  • Focuses on clinical presentation, risk factors, and management strategies.

Main Results:

  • Patients with hematologic malignancies are at increased risk for developing DKA or HHNS, particularly secondary to cancer-related stress and treatment.
  • These conditions present as complex syndromes characterized by severe hyperglycemia, metabolic acidosis, and potential for systemic collapse.

Conclusions:

  • Healthcare providers must maintain a high index of suspicion for DKA and HHNS in patients with hematologic malignancies.
  • Collaborative care involving critical care teams and nurses is essential for optimal management of these challenging diabetic complications.

Related Concept Videos